TRIB

Q: What is the price of Trinity Biotech (TRIB) today?

The current price of Trinity Biotech (TRIB) is $ 0.57, representing a -6.56% gain over the past year. The stock began the year trading around $ 0.79 and is currently priced at $ 0.57. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Trinity Biotech (TRIB) pay dividends?

Trinity Biotech (TRIB) did not pay dividends over the past year.

Trinity Biotech PLC

Price

$ 0.57

return (12m)

-6.56%

p/e

-0.18

p/bv

-0.17

DIVIDEND YIELD

0.00%

TRIB price

Trinity Biotech

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment TRIB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

-12.51%

1 year

-6.56%

2 years

-77.65%

5 years

-96.12%

10 years

-98.95%

Fundamentals TRIB

review the fundamentals of Trinity Biotech shares

P/E

-0.18

Sector: -1.71 Industry: 7.55

P/S (PSR)

0.12

Sector: 1.98 Industry: 3.02

P/BV

-0.17

Sector: 2.11 Industry: 3.05

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-65.75%

Sector: -28.05% Industry: -3.96%

ROE

96.07%

Sector: -33.97% Industry: -15.35%

ROIC

-5.82%

Sector: -441.74% Industry: -13.19%

NET MARGIN

-65.64%

Sector: -29.81% Industry: -7.51%

GROSS MARGIN

36.40%

Sector: 45.08% Industry: 54.39%

OPERATING MARGIN

-23.85%

Sector: -24.71% Industry: -3.69%

EV/EBITDA

-0.32

Sector: -0.10 Industry: 7.39

EV/EBIT

-0.29

Sector: -1.70 Industry: 7.01

PRICE-TO-ASSETS

0.12

Sector: 1.17 Industry: 1.27

BVPS

-3.79

Sector: 3.83 Industry: 8.68

EPS

-3.64

Sector: -0.90 Industry: 0.05

EQUITY-TO-ASSETS RATIO

-0.68

Sector: 0.43 Industry: 0.48

LIABILITIES / ASSETS

1.68

Sector: 0.46 Industry: 0.52

CAGR REVENUE 5 YEARS

5.36%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals TRIB

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.12	32.50	81.02%	0.57%	$ 1.01 T	34.99%
ISRG	48.98	8.29	16.93%	0.00%	$ 145.93 B	28.15%
SNY	7.23	1.29	17.79%	3.99%	$ 108.01 B	14.75%
TMO	25.50	3.35	13.15%	0.38%	$ 174.59 B	15.15%
NVS	21.59	7.51	34.77%	2.03%	$ 292.21 B	23.92%
ABT	23.76	2.83	11.91%	2.85%	$ 149.12 B	13.91%
MDT	21.42	0.00	-%	3.54%	$ 102.82 B	13.20%
GSK	13.49	4.56	33.77%	3.33%	$ 105.82 B	17.79%
CVS	44.27	1.67	3.78%	2.61%	$ 129.80 B	0.72%
BSX	19.67	2.71	13.78%	0.00%	$ 70.13 B	17.29%
TMDX	14.42	5.02	34.80%	0.00%	$ 2.48 B	27.04%
IDXX	40.97	28.84	70.38%	0.00%	$ 44.87 B	24.63%
HCA	12.77	-29.12	-228.14%	0.76%	$ 86.73 B	8.89%
RMD	18.53	4.34	23.41%	0.93%	$ 28.16 B	27.44%
DHR	34.57	2.41	6.97%	0.76%	$ 127.51 B	14.89%
PHG	22.29	1.91	8.56%	3.83%	$ 25.19 B	5.50%
INMD	9.72	1.28	13.18%	0.00%	$ 847.35 M	23.27%
SYK	35.73	5.19	14.52%	1.11%	$ 119.24 B	13.21%
CI	12.12	1.87	15.39%	2.04%	$ 78.74 B	2.34%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TRIB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/05/2015	07/01/2015	1,10000000
Dividends	06/06/2014	07/01/2014	1,10000000
Dividends	06/06/2013	07/01/2013	1,00000000
Dividends	06/06/2012	06/22/2012	0,75000000
Dividends	06/07/2011	06/23/2011	2,00000000

ABOUT Trinity Biotech

Trinity Biotech PLC

Average Investor10 user rating

4.0 (0 people)

United States

34 years

Founded: 1992

1992

Time since IPO - 34 years

543

Employees

Trinity Biotech PLC (United States) is listed on the Nasdaq and has a market capitalization of $12.35 Millions, with shareholders equity totaling $-71.98 Millions.

The company employs approximately 543 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Trinity Biotech PLC reported $105.34 Millions in revenue, generating net income of $-69.15 Millions.

Key financial metrics include a P/E ratio of -0.18, a price-to-book (P/B) ratio of -0.17, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TRIB.

Market cap

$ 12.35 Millions

Net worth

$ -71.98 Millions

$ -71,980,000.00

Assets

$ 105.17 Millions

$ 105,170,000.00

Total Shares Outstanding

19.00 Millions

19,000,000

Average Daily Trading Volume

$ 112.93 Thousand

$ 112,926.00

Sector

Health

Industry

Medical Supplies and Equipment

TRIB

TRIB revenue and profits

Financial Results TRIB

DRAG THE FRAME TO SEE MORE DATA

TRIB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CVS - CVS Health

$ 100.72 55,60% (12M)

P/E

44.27

2.61%

ROE

3.78%

P/BV

1.67

CI - Cigna

$ 291.88 --4,54% (12M)

P/E

12.12

2.04%

ROE

15.39%

P/BV

1.87

CNC - Centene

$ 61.39 11,80% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$ 369.49 55,80% (12M)

P/E

40.27

0.93%

ROE

6.06%

P/BV

2.44

SNY - Sanofi

$ 44.05 --5,05% (12M)

P/E

7.23

3.99%

ROE

17.79%

P/BV

1.29

LLY - Eli Lilly

$ 1,122.50 48,21% (12M)

P/E

40.12

0.57%

ROE

81.02%

P/BV

32.50

HCA - HCA Healthcare

$ 396.93 7,48% (12M)

P/E

12.77

0.76%

ROE

-228.14%

P/BV

-29.12

NVS - Novartis

$ 150.93 32,17% (12M)

P/E

21.59

2.03%

ROE

34.77%

P/BV

7.51

CVS - CVS Health

$ 100.72 55,60% (12 M)

P/L

44.27

2.61%

ROE

3.78%

P/VP

1.67

CI - Cigna

$ 291.88 --4,54% (12 M)

P/L

12.12

2.04%

ROE

15.39%

P/VP

1.87

CNC - Centene

$ 61.39 11,80% (12 M)

P/L

-4.98

0.00%

ROE

-29.93%

P/VP

1.49

HUM - Humana

$ 369.49 55,80% (12 M)

P/L

40.27

0.93%

ROE

6.06%

P/VP

2.44

SNY - Sanofi

$ 44.05 --5,05% (12 M)

P/L

7.23

3.99%

ROE

17.79%

P/VP

1.29

LLY - Eli Lilly

$ 1,122.50 48,21% (12 M)

P/L

40.12

0.57%

ROE

81.02%

P/VP

32.50

HCA - HCA Healthcare

$ 396.93 7,48% (12 M)

P/L

12.77

0.76%

ROE

-228.14%

P/VP

-29.12

NVS - Novartis

$ 150.93 32,17% (12 M)

P/L

21.59

2.03%

ROE

34.77%

P/VP

7.51

Frequently Asked Questions

What is the price of Trinity Biotech (TRIB) today?

The current price of Trinity Biotech (TRIB) is $ 0.57, representing a -6.56% gain over the past year. The stock began the year trading around $ 0.79 and is currently priced at $ 0.57. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Trinity Biotech (TRIB) pay dividends?

Trinity Biotech (TRIB) did not pay dividends over the past year.

Is Trinity Biotech (TRIB) a good investment?

Trinity Biotech (TRIB) is currently trading at $ 0.57 with a P/E ratio of -0.18. This represents a -40% premium compared to its historical average P/E. Over the past year, the stock has gained -6.56 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -6.56%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Trinity Biotech (TRIB) stock?

You can buy Trinity Biotech (TRIB) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol TRIB and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Trinity Biotech (TRIB) yield today?

Over the past month, Trinity Biotech (TRIB) has returned 0.00% — -6.56% over the past year, and -96.12% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Trinity Biotech (TRIB) today at the current price of $ 0.57 your total investment would be $ 57.00.

Based on historical performance, the investment would have grown to approximately:

$ 53.26 after 1 year
$ 2.21 after 5 years
$ 0.60 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

TRIB

Trinity Biotech PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment TRIB

review the fundamentals of Trinity Biotech shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Trinity Biotech

Trinity Biotech PLC

United States

34 years

1992

543

PROFIT X PRICE TRIB

Financial Results TRIB

TRIB cash flow

Asset, Revenue and Profit Growth - TRIB

TRIB balance sheet

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions